GWILX
Price
$16.33
Change
+$0.07 (+0.43%)
Updated
Jul 25 closing price
Net Assets
18.16M
RMFEX
Price
$60.79
Change
+$0.27 (+0.45%)
Updated
Jul 25 closing price
Net Assets
110.54B
Interact to see
Advertisement

GWILX vs RMFEX

Header iconGWILX vs RMFEX Comparison
Open Charts GWILX vs RMFEXBanner chart's image
Glenmede Women in Leadership US Eq
Price$16.33
Change+$0.07 (+0.43%)
VolumeN/A
Net Assets18.16M
American Funds American Mutual R4
Price$60.79
Change+$0.27 (+0.45%)
VolumeN/A
Net Assets110.54B
GWILX vs RMFEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GWILX vs. RMFEX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GWILX is a Buy and RMFEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 111B vs. GWILX (18.2M). RMFEX pays higher dividends than GWILX: RMFEX (1.53) vs GWILX (0.75). GWILX was incepted earlier than RMFEX: GWILX (10 years) vs RMFEX (23 years). GWILX (1.16) is less costly to investors than RMFEX (0.62). GWILX is a more actively managed with annual turnover of: 80.00 vs. RMFEX (31.00). GWILX has a lower initial minimum investment than RMFEX: GWILX (0) vs RMFEX (250). RMFEX annual gain was more profitable for investors over the last year : 11.74 vs. GWILX (2.41). RMFEX return over 5 years is better than : 62.99 vs. GWILX (28.67).
GWILXRMFEXGWILX / RMFEX
Total Expense Ratio0.850.62137%
Annual Report Gross Expense Ratio1.160.62187%
Fund Existence10 years23 years-
Gain YTD6.37411.52755%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets18.2M111B0%
Annual Yield % from dividends0.751.5349%
Returns for 1 year2.4111.7421%
Returns for 3 years23.5632.0873%
Returns for 5 years28.6762.9946%
Returns for 10 yearsN/A88.96-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BEAM21.720.77
+3.68%
Beam Therapeutics
ESPR1.510.02
+1.34%
Esperion Therapeutics
BMRN59.01-0.75
-1.26%
BioMarin Pharmaceutical
TOUR0.86-0.02
-2.16%
Tuniu Corp
IMTE1.15-0.11
-8.73%
Integrated Media Technology Limited